Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AIdentity is a pioneering biotechnology company focused on decoding cellular identity to transform drug discovery and diagnostics. Co-founded by renowned oncologist Siddhartha Mukherjee and serial entrepreneur Maneesh Jain, the company utilizes an AI-driven platform to map the complex states of cells in health and disease. By integrating high-dimensional biological data with advanced machine learning, AIdentity aims to identify novel therapeutic targets and biomarkers that define cellular transitions. The company is primarily focused on applications in oncology and immunology, seeking to develop precision medicines based on a deep understanding of cellular identity. Backed by Matrix Capital Management, AIdentity operates at the intersection of machine learning and deep biology to unlock new avenues for treating complex diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AIdentity Matrix.